274 related articles for article (PubMed ID: 26990912)
1. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
[TBL] [Abstract][Full Text] [Related]
2. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
Chen S; Jiang Y; Yu C; Li Y
Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
Brookshire HL; English RV; Nadelstein B; Weigt AK; Gift BW; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):175-85. PubMed ID: 24636042
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
[TBL] [Abstract][Full Text] [Related]
6. Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.
Silverstein SM; Cable MG; Sadri E; Peace JH; Fong R; Chandler SP; Gow JA; Klier SM; McNamara TR;
Curr Med Res Opin; 2011 Sep; 27(9):1693-703. PubMed ID: 21751945
[TBL] [Abstract][Full Text] [Related]
7. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
Walters TR; Goldberg DF; Peace JH; Gow JA;
Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
[TBL] [Abstract][Full Text] [Related]
8. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
[TBL] [Abstract][Full Text] [Related]
9. The systemic safety of bromfenac ophthalmic solution 0.09%.
Stewart RH; Grillone LR; Shiffman ML; Donnenfeld ED; Gow JA;
J Ocul Pharmacol Ther; 2007 Dec; 23(6):601-12. PubMed ID: 18001250
[TBL] [Abstract][Full Text] [Related]
10. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
[TBL] [Abstract][Full Text] [Related]
11. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
[TBL] [Abstract][Full Text] [Related]
12. Acute corneal melt associated with topical bromfenac use.
Prasher P
Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
15. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Bucci FA; Waterbury LD
Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
[TBL] [Abstract][Full Text] [Related]
16. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
Kashiwagi K; Tsukahara S
Br J Ophthalmol; 2003 Mar; 87(3):297-301. PubMed ID: 12598441
[TBL] [Abstract][Full Text] [Related]
17. Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.
Hoy SM
Clin Drug Investig; 2015 Aug; 35(8):525-9. PubMed ID: 26177719
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 2 regimens of loteprednol etabonate and bromfenac for cataract surgery.
Al-Awadi A; Tokko HA; Chan CC; Somani S
Can J Ophthalmol; 2019 Jun; 54(3):388-394. PubMed ID: 31109481
[TBL] [Abstract][Full Text] [Related]
19. Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1.
Coassin M; De Maria M; Mastrofilippo V; Braglia L; Cimino L; Sartori A; Fontana L
Adv Ther; 2019 Oct; 36(10):2712-2722. PubMed ID: 31482510
[TBL] [Abstract][Full Text] [Related]
20. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
Hessemer V; Schmitt K; Jacobi A
Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
